Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States

Clinical Infectious Diseases

Volumn 57, Issue 3, 2013, Pages 344-348

  Mandal, Sema ^a   Wu, Henry M ^a   MacNeil, Jessica R ^a   Machesky, Kimberly ^b   Garcia, Jocelyn ^a   Plikaytis, Brian D ^a   Quinn, Kim ^b   King, Larry ^b   Schmink, Susanna E ^a   Wang, Xin ^a   Mayer, Leonard W ^a   Clark, Thomas A ^a   Gaskell, James R ^c   Messonnier, Nancy E ^a   DiOrio, Mary ^b   Cohn, Amanda C ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b OHIO DEPARTMENT OF HEALTH   (United States)

^c Athens City County Health Department   (United States)

Author keywords

Meningococcal disease; Outbreak; Risk factors; Serogroup B; University

Indexed keywords

MENINGOCOCCUS VACCINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GEL ELECTROPHORESIS; HUMAN; MALE; MENINGOCOCCOSIS; MOLECULAR TYPING; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; UNIVERSITY STUDENT;

MENINGOCOCCAL DISEASE; OUTBREAK; RISK FACTORS; SEROGROUP B; UNIVERSITY;

ADOLESCENT; CASE-CONTROL STUDIES; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; MENINGITIS, MENINGOCOCCAL; NEISSERIA MENINGITIDIS, SEROGROUP B; QUESTIONNAIRES; RISK FACTORS; SEROTYPING; UNITED STATES; UNIVERSITIES; YOUNG ADULT;

EID: 84880353023     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit243     Document Type: Article

References (22)

1. Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 2010; 50:184-91.
2. Edwards MS, Baker CJ. Complications and sequelae of meningococcal infections in children. J Pediatr 1981; 99:540-5.
3. Kirsch EA, Barton RP, Kitchen L, Giroir BP. Pathophysiology, treatment and outcome of meningococcemia: a review and recent experience. Pediatr Infect Dis J 1996; 15:967-78.
4. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005; 54(RR-7):1-21.
5. Brooks R, Woods CW, Benjamin DK Jr, Rosenstein NE. Increased casefatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002. Clin Infect Dis 2006; 43:49-54.
6. Council of State and Territorial Epidemiologists (CSTE). Revision of the national surveillance case definition for meningococcal disease. 09-ID-42. Atlanta, Georgia. Available at: http://www.cste.org. Accessed 25 October 2012.
7. Mothershed EA, Sacchi CT, Whitney AM, et al. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol 2004; 42:320-8.
8. Dolan Thomas J, Hatcher CP, Satterfield DA, et al. sodC-Based real-time PCR for detection of Neisseria meningitidis. PLoSOne 2011; 6:e19361.
9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 18th informational supplement. In: CLSI document M100-S18.Wayne, PA: CLSI, 2008.
10. Popovic T, Schmink S, Rosenstein NA, et al. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol 2001; 39:75-85.
11. Maiden MC, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 1998; 95:3140-5.
12. Neisseria Sequence Typing Home Page. FetA and MLST typing information [database on the Internet]. Available at: http://pubmlst.org/neisseria/. Accessed 25 October 2012.
13. Harrison LH, Shutt KA, Schmink SE, et al. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the premeningococcal conjugate vaccine era - United States, 2000-2005. J Infect Dis 2010; 201:1208-24.
14. Law DK, Lorange M, Ringuette L, et al. Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19). J Clin Microbiol 2006; 44:2743-9.
15. Lucidarme J, Comanducci M, Findlow J, et al. Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales. J Clin Microbiol 2009; 47:3577-85.
16. Delisle E, Larrieu S, Simoes J, et al. Community outbreak of group B meningococcal disease in southwest France - December 2008 to September 2009. Euro Surveill 2010; 15.
17. Diermayer M, Hedberg K, Hoesly F, et al. Epidemic serogroup B meningococcal disease in Oregon: the evolving epidemiology of the ET-5 strain. JAMA 1999; 281:1493-7.
18. Rouaud P, Perrocheau A, Taha MK, et al. Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005. Euro Surveill 2006; 11:178-81.
19. Lewis S, Sadarangani M, Hoe JC, Pollard AJ. Challenges and progress in the development of a serogroup B meningococcal vaccine. Expert Rev Vaccines 2009; 8:729-45.
20. Cohn AC, Messonnier NE. Inching toward a serogroup B meningococcal vaccine for infants. JAMA 2012; 307:614-5.
21. Tan LK, Carlone GM, Borrow R. Advances in the development of vaccines against Neisseria meningitidis. N Engl J Med 2010; 362: 1511-20.
22. Santolaya M, ed. Immunogenicity and tolerability of an investigational multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents. In: 29th European Society for Paediatric Infectious Diseases Conference, The Hague, Netherlands, 7-11 June 2011.